EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
EXTRA-PC：一项针对初治转移性激素敏感性前列腺癌患者的马索法尼汀（EPI-7386）联合恩扎卢胺的II期临床试验
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf434
Jang, Albert; Fowler, Peggy; Helminiak, Kathryn; Kumar, Hamsa L S; Pasucal, Jeffrey; Delong, Victoria; Zhong, Jeffrey Y; Jindal, Tanya; Grier, Abby L; Patel, Rishi R; Hislop, Mary; Cesano, Alessandra; Villaluna, Karen; Younginger, Brett; Wolff, Kayla; Richey, Kara; Bray, Julie; Garcia, Hannah; Adamowicz, Timothy; Reese, Amy; Nizam, Amanda; Gupta, Shilpa; Wee, Christopher E; Margevicius, Seunghee; Fu, Pingfu; Mendiratta, Prateek; Sheng, Iris Y; Brown, Jason R; Garcia, Jorge A; Barata, Pedro C
